This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2024-06-14), ConvaTec Group's share price is £2.53. ConvaTec Group's Median PS Value is £0.00. Therefore, ConvaTec Group's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for ConvaTec Group's Median PS Value or its related term are showing as below:
LSE:CTEC's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.82 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
ConvaTec Group Median PS Value Historical Data
The historical data trend for ConvaTec Group's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ConvaTec Group's Median PS Value
For the Medical Instruments & Supplies subindustry, ConvaTec Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ConvaTec Group's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ConvaTec Group's Price-to-Median-PS-Value falls into.
ConvaTec Group Median PS Value Calculation
ConvaTec Group's Median PS Value for today is calculated as
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.826.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ConvaTec Group (LSE:CTEC) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ConvaTec Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.53
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ConvaTec Group Median PS Value Related Terms
Thank you for viewing the detailed overview of ConvaTec Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:CTEC has been successfully added to your 